BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15827777)

  • 1. Beyond the clinical trials: how often is sentinel lymph node dissection performed for breast cancer?
    Maggard MA; Lane KE; O'Connell JB; Nanyakkara DD; Ko CY
    Ann Surg Oncol; 2005 Jan; 12(1):41-7. PubMed ID: 15827777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
    J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
    Khakpour N; Hunt KK; Kuerer HM; Yi M; Meric-Bernstam F; Ross MI; Lucci A
    Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
    Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
    J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma.
    Swenson KK; Mahipal A; Nissen MJ; Tuttle TM; Heaton K; Lally RM; Spomer A; Lee MW
    Cancer; 2005 Nov; 104(9):1834-9. PubMed ID: 16161037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast sentinel lymph node dissection before preoperative chemotherapy.
    Grube BJ; Christy CJ; Black D; Martel M; Harris L; Weidhaas J; Digiovanna MP; Chung G; Abu-Khalaf MM; Miller KD; Higgins SA; Philpotts L; Tavassoli FA; Lannin DR
    Arch Surg; 2008 Jul; 143(7):692-9; discussion 699-700. PubMed ID: 18645113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
    Lucci A; McCall LM; Beitsch PD; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
    J Clin Oncol; 2007 Aug; 25(24):3657-63. PubMed ID: 17485711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node evaluation in colorectal cancer patients: a population-based study.
    Baxter NN; Virnig DJ; Rothenberger DA; Morris AM; Jessurun J; Virnig BA
    J Natl Cancer Inst; 2005 Feb; 97(3):219-25. PubMed ID: 15687365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
    Gipponi M
    Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with variance in compliance with a sentinel lymph node dissection quality measure in early-stage breast cancer.
    Olaya W; Wong J; Morgan JW; Truong C; Roy-Chowdhury S; Kazanjian K; Lum S
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():297-302. PubMed ID: 20853050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer?
    Hieken TJ; Velasco JM
    Surgery; 2006 Oct; 140(4):500-7; discussion 507-8. PubMed ID: 17011896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting failure to identify a sentinel lymph node in breast cancer.
    Chagpar AB; Martin RC; Scoggins CR; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; Ley PB; Tuttle TM; McMasters KM
    Surgery; 2005 Jul; 138(1):56-63. PubMed ID: 16003317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of sentinel node biopsy and stage migration of breast cancer.
    van der Heiden-van der Loo M; Bezemer PD; Hennipman A; Siesling S; van Diest PJ; Bongers V; Peeters PH
    Eur J Surg Oncol; 2006 Sep; 32(7):710-4. PubMed ID: 16765560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.
    Cox C; White L; Allred N; Meyers M; Dickson D; Dupont E; Cantor A; Ly Q; Dessureault S; King J; Nicosia S; Vrcel V; Diaz N
    Ann Surg Oncol; 2006 May; 13(5):708-11. PubMed ID: 16538416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ratios of involved nodes in early breast cancer.
    Vinh-Hung V; Verschraegen C; Promish DI; Cserni G; Van de Steene J; Tai P; Vlastos G; Voordeckers M; Storme G; Royce M
    Breast Cancer Res; 2004; 6(6):R680-8. PubMed ID: 15535850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.